Articles On Uscom (ASX:UCM)

Source: Have a nice day Photo, Shutterstock Summary Telix Pharmaceuticals has announced the launch of NOBLE Registry of its prostate cancer imaging agent. Global healthcare company Ramsay Health Care confirms the funding guarantee arr...

China’s economy is forecast to grow at a rate of 7 to 9 per cent in 2021, according to consensus estimates Chinese households and consumers have amassed a pool of wealth amid China’s economic rise and have spare cash to spend Several ASX c...

Medical device manufacturer Uscom Ltd (ASX: UCM) has today announced a significant increase in its sales and profits for the first 5 months of FY21. The Uscom share price lifted by 10% after the announcement, and is currently trading at 17...

Summary Uscom Limited informed the market today that Uscom China got listed as a National High Technology Enterprise. The National High Technology Entities are recognised as a national value. They are offered special assistance by seve...

A quick wrap of the ASX’s key winners and losers on Monday, July 13. Data is taken after the market closes at 4pm EST. Stocks highlighted in yellow made potentially market-moving announcements during the day. Today 715 stocks rose, 639 decl...

In the past fortnight there were over 30 directors trades of $100,000 or more among ASX small cap directors. The list included multiple groups of directors. Five directors from water treatment stock Phoslock (ASX:PET) put in $1.3m between t...

Our summary of Uscom Ltd's recent announcement What's happened? Uscom Limited (ASX:UCM) today announced the signing of a development and supply agreement with A&D Limited of Japan. What are the key highlights? The agreement relates to...

The announcement lands just before markets open, ‘the TGA has approved our device’; the buy orders begin to pile up and the pre-open share price begins to surge. But while a nod from Australia’s drug and device regulator, the Therapeutic Go...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

As with the early medical cannabis plays, a cluster of ASX-listed stocks has wasted little time attaching itself to the ‘c’ word. We’re talking of course about the coronavirus COVID-19 but sadly not another ‘c’ word: cure. Or not yet. Accor...

The spread of coronavirus has infected global share markets with the contagion of fear. The S&P/ASX 200 Index (INDEXASX: XJO) has fallen more than 10% in the last fortnight as investors flee to safe havens. This week, the Reserve Bank...

In February, mounting coronavirus-led uncertainty finally culminated in a late-month share price bloodbath. After a 3 per cent gain in January, the S&P/ASX Emerging Companies Index – which gauges the health of the microcap sector – had...

Last week markets had their worst week since the global financial crisis (GFC) and the carnage, at least on the ASX, continued yesterday. A virus that began at a live meat market in Wuhan has now spread to over 80,000 people globally and th...

The Uscom Ltd (ASX: UCM) share price rocketed higher today following the announcement that the Chinese government has recommended one of its products for use in treating coronavirus. After surging as much as 38.7% in afternoon trade, Uscom...

Australian medical technology company Uscom (ASX: UCM) has posted a 35% drop in total revenue figures for the half-year ending December 2019, underpinned by a restructure to its China-based distribution model. In January, the company commis...

For weeks Zoono (ASX:ZNO) shares have surged as people demand its products wanting to protect themselves from the coronavirus, but maybe this wasn’t panic buying after all. This morning the hand sanitiser maker revealed the test results of...

As the coronavirus death toll rises to more than 1,000 and the World Health Organisation labels it a global health emergency, share markets are feeling the impact of the outbreak with Australian ASX-listed stocks not immune to the damage. C...

Today’s session proved much kinder to the Aussie market, delivering strong gains across the board as China’s factories came back online. While the dollar remained fairly stagnant, sectors, futures and indices did a 180, rallying to rever...

Australian shares rose to a two-week high as investors weighed positive overnight leads against the impact of bushfires and the coronavirus on company earnings. The ASX 200 advanced 51 points or 0.7 per cent to 7063, the index’s highest...

Two more coronavirus infections were released to the ASX in the last 24 hours, but while one was bad, it turns out the other wasn’t part of the epidemic at all. Uscom (ASX:UCM) says sales of its haemodynamic monitoring device in China, whic...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

The ongoing coronavirus outbreak in China is making itself felt in a commercial sense as medical technology company Uscom (ASX: UCM), a supplier of monitoring devices, announced a material increase in orders for its USCOM 1A device in China...

Over the past five weeks, Uscom (UCM) has received a material increase in demand for its USCOM 1A device in China The device is used to optimise the management of infectious diseases and accurately measures blood flow, cardiac output and...

A fresh decade-low for the dollar ended today’s session on a weak note, leaving Australian markets in the red. Despite attempts to climb against the greenback later in the day, the dollar was worth as little as 66.6 US cents this morning...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

With triple the number of sepsis cases in Australia, small cap biotech company Cynata Therapeutics (ASX:CYP) hopes to wage a new war on blood infections. Last Friday the world learned blood infections were on the rise, with researchers show...

Uscom (UCM) says the China National Medical Administration has certified extended sales of the USCOM 1A device China This certification is valid for five years and is the third consecutive approval for the device This approval allows cur...

Did you know that a hard-working stallion ejaculates 100 times more sperm than the average bloke? Given a virile, but weary, thoroughbred can service hundreds of mares in a breeding season, that’s just as well. But even the most virile of t...

Uscom Limited (ASX: UCM), an innovative medical technology company, has appointed four new US dealers to assist a new US sales and marketing strategy. The appointments of the new dealers assure that they will cover approximately 75% of the...

Ever since the advent of TV, worried parents have cautioned their kids that too much time in front of John Logie Baird’s infernal device will make them go blind – a warning routinely shrugged off by the juvenile couch potatoes. It seems tha...

We hate to sound like an old school report, but it’s been a year of steady and solid progress for the maker of non-invasive cardiac and pulmonary measuring devices, especially in its key target market of China. Achievements include record r...

Uscom Limited (ASX: UCM), an innovative medical technology company, announced the appointment of a new European Sales and marketing Manager, Dr Antonio Ferrario, who will co-ordinate the newly established Uscom sales and marketing hub in Bu...

International research suggests shares in companies that buy in their own equities are more likely to respond positively through share price appreciation. Investors should note, however, buying back own stock is not a guarantee of significa...

The Australian economy is the 14th largest economy in the world and is being awarded a AAA rating by all the three global rating agencies around the world. Since 1992 till 2018, Australia has seen a continuous annual economic growth. Robust...

International research suggests shares in companies that buy in their own equities are more likely to respond positively through share price appreciation. Investors should note, however, buying back own stock is not a guarantee of significa...

International research suggests shares in companies that buy in their own equities are more likely to respond positively through share price appreciation. Investors should note, however, buying back own stock is not a guarantee of significa...

International research suggests shares in companies that buy in their own equities are more likely to respond positively through share price appreciation. Investors should note, however, buying back own stock is not a guarantee of significa...

International research suggests shares in companies that buy in their own equities are more likely to respond positively through share price appreciation. Investors should note, however, buying back own stock is not a guarantee of significa...

International research suggests shares in companies that buy in their own equities are more likely to respond positively through share price appreciation. Investors should note, however, buying back own stock is not a guarantee of significa...

International research suggests shares in companies that buy in their own equities are more likely to respond positively through share price appreciation. Investors should note, however, buying back own stock is not a guarantee of significa...

Uscom Ltd’s (ASX:UCM) result for the three months to June 30, 2019 featured robust cash receipts with the company finishing fiscal 2019 strongly with June quarter cash income of $780,000, up 47% from $530,000 in the previous corresponding p...

The benchmark index S&P/ASX 200 is trading at 6,665.7 on 10 July 2019 (AEST 01:58 PM), up 0.45%, while the S&P/ASX 200 Health Care Index is up 0.4% to 34,275.1. Let us discuss three healthcare stocks listed on ASX, along with their...